|
MLL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.820200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.958000E-01 |
| Normal-vs-Stage2 |
7.138200E-01 |
| Normal-vs-Stage3 |
2.583600E-01 |
| Normal-vs-Stage4 |
5.676500E-02 |
| Stage1-vs-Stage2 |
2.246200E-01 |
| Stage1-vs-Stage3 |
8.302600E-03 |
| Stage1-vs-Stage4 |
6.384600E-04 |
| Stage2-vs-Stage3 |
5.675000E-01 |
| Stage2-vs-Stage4 |
2.349000E-01 |
| Stage3-vs-Stage4 |
3.653400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.531600E-01 |
| Normal-vs-AfricanAmerican |
7.670600E-01 |
| Normal-vs-Asian |
6.039800E-02 |
| Caucasian-vs-AfricanAmerican |
5.143400E-01 |
| Caucasian-vs-Asian |
5.896200E-02 |
| AfricanAmerican-vs-Asian |
1.735420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.703800E-01 |
| Normal-vs-Female |
3.795600E-01 |
| Male-vs-Female |
2.104200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.967800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.343000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.123800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.840980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.148600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.686600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.006400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.645900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.176400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.631800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.001700E-04 |
| Normal-vs-Grade 2 |
4.465000E-01 |
| Normal-vs-Grade 3 |
3.077800E-01 |
| Normal-vs-Grade 4 |
4.456300E-02 |
| Grade 1-vs-Grade 2 |
3.423800E-03 |
| Grade 1-vs-Grade 3 |
3.42890000004648E-06 |
| Grade 1-vs-Grade 4 |
9.75990000040561E-07 |
| Grade 2-vs-Grade 3 |
2.196100E-02 |
| Grade 2-vs-Grade 4 |
2.024400E-03 |
| Grade 3-vs-Grade 4 |
1.559400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.815200E-01 |
| Normal-vs-ccB subtype |
5.921000E-01 |
| ccA subtype-vs-ccB subtype |
6.799800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.341200E-01 |
| Normal-vs-N1 |
4.335200E-01 |
| N0-vs-N1 |
5.350200E-01 |
|
|
